Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 May;60(5):572–575. doi: 10.1136/jnnp.60.5.572

A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis.

E Paolino 1, E Fainardi 1, P Ruppi 1, M R Tola 1, V Govoni 1, I Casetta 1, V C Monetti 1, E Granieri 1, M Carreras 1
PMCID: PMC486374  PMID: 8778266

Abstract

A prospective study in patients with a clinical acute isolated brainstem or spinal cord disorder was undertaken. The aim was to evaluate the predictive value of IgG intrathecal synthesis (through the detection of oligoclonal bands in CSF) and MRI lesions at presentation, for the subsequent progression to multiple sclerosis. Forty four patients took part in this study: 22 had a brainstem disorder and 22 a spinal cord disorder. After a mean period of 26 (SD 22) months, 30 patients (68.2%) developed clinically definite multiple sclerosis. The remaining 14 patients were followed up for more than seven years. Twenty six (59.1%) patients had oligoclonal bands in CSF, with a sensitivity of 80.0%, specificity of 85.7%, and a predictive value of 92.2%. Magnetic resonance imaging showed disseminated white matter lesions in 22 patients (50.0%), with a sensitivity of 60.0%, a specificity of 71.4%, and a predictive value of 81.7%. The difference between patients with multiple sclerosis and patients without the disease was statistically significant for the findings of an IgG intrathecal synthesis (P < 0.001). It was only borderline for the MRI findings (P = 0.052). Thus the detection of an intrathecal synthesis at presentation seemed to be a better prognostic indicator of the progression to multiple sclerosis in patients affected by acute isolated brainstem or spinal cord syndromes.

Full text

PDF
572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Delmotte P., Gonsette R. Biochemical findings in multiple sclerosis IV. Isoelectric focusing of the CSF gamma globulins in multiple sclerosis (262 cases) and other neurological diseases (272 cases). J Neurol. 1977 Apr 28;215(1):27–37. doi: 10.1007/BF00312547. [DOI] [PubMed] [Google Scholar]
  2. Delpech B., Lichtblau E. Etude quantitative des immunoglobulines G et de l'albumine du liquide cephalo rachidien. Clin Chim Acta. 1972 Mar;37:15–23. doi: 10.1016/0009-8981(72)90410-x. [DOI] [PubMed] [Google Scholar]
  3. Ebers G. C., Paty D. W. CSF electrophoresis in one thousand patients. Can J Neurol Sci. 1980 Nov;7(4):275–280. doi: 10.1017/s0317167100022733. [DOI] [PubMed] [Google Scholar]
  4. Farlow M. R., Markand O. N., Edwards M. K., Stevens J. C., Kolar O. J. Multiple sclerosis: magnetic resonance imaging, evoked responses, and spinal fluid electrophoresis. Neurology. 1986 Jun;36(6):828–831. doi: 10.1212/wnl.36.6.828. [DOI] [PubMed] [Google Scholar]
  5. Frederiksen J. L., Larsson H. B., Henriksen O., Olesen J. Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand. 1989 Dec;80(6):512–517. doi: 10.1111/j.1600-0404.1989.tb03919.x. [DOI] [PubMed] [Google Scholar]
  6. Gebarski S. S., Gabrielsen T. O., Gilman S., Knake J. E., Latack J. T., Aisen A. M. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol. 1985 May;17(5):469–474. doi: 10.1002/ana.410170509. [DOI] [PubMed] [Google Scholar]
  7. Giesser B. S., Kurtzberg D., Vaughan H. G., Jr, Arezzo J. C., Aisen M. L., Smith C. R., LaRocca N. G., Scheinberg L. C. Trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of multiple sclerosis. Arch Neurol. 1987 Mar;44(3):281–284. doi: 10.1001/archneur.1987.00520150035017. [DOI] [PubMed] [Google Scholar]
  8. Gilmore R. L., Kasarskis E. J., Carr W. A., Norvell E. Comparative impact of paraclinical studies in establishing the diagnosis of multiple sclerosis. Electroencephalogr Clin Neurophysiol. 1989 Nov;73(5):433–442. doi: 10.1016/0013-4694(89)90093-x. [DOI] [PubMed] [Google Scholar]
  9. Kostulas V. K. Oligoclonal IgG bands in cerebrospinal fluid. Methodological and clinical aspects. Acta Neurol Scand Suppl. 1985;103:1–112. [PubMed] [Google Scholar]
  10. Laterre E. C., Callewaert A., Heremans J. F., Sfaello Z. Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology. 1970 Oct;20(10):982–990. doi: 10.1212/wnl.20.10.982. [DOI] [PubMed] [Google Scholar]
  11. Lee K. H., Hashimoto S. A., Hooge J. P., Kastrukoff L. F., Oger J. J., Li D. K., Paty D. W. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1991 May;41(5):657–660. doi: 10.1212/wnl.41.5.657. [DOI] [PubMed] [Google Scholar]
  12. Link H., Müller R. Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol. 1971 Oct;25(4):326–344. doi: 10.1001/archneur.1971.00490040052007. [DOI] [PubMed] [Google Scholar]
  13. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest. 1977 Sep;37(5):397–401. doi: 10.1080/00365517709091498. [DOI] [PubMed] [Google Scholar]
  14. Martí-Fàbregas J., Martínez J. M., Illa I., Escartín A. Myelopathy of unknown etiology. A clinical follow-up and MRI study of 57 cases. Acta Neurol Scand. 1989 Nov;80(5):455–460. doi: 10.1111/j.1600-0404.1989.tb03909.x. [DOI] [PubMed] [Google Scholar]
  15. Miller D. H., Ormerod I. E., Rudge P., Kendall B. E., Moseley I. F., McDonald W. I. The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol. 1989 Nov;26(5):635–639. doi: 10.1002/ana.410260508. [DOI] [PubMed] [Google Scholar]
  16. Morrissey S. P., Miller D. H., Kendall B. E., Kingsley D. P., Kelly M. A., Francis D. A., MacManus D. G., McDonald W. I. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain. 1993 Feb;116(Pt 1):135–146. doi: 10.1093/brain/116.1.135. [DOI] [PubMed] [Google Scholar]
  17. Moulin D., Paty D. W., Ebers G. C. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis. Brain. 1983 Dec;106(Pt 4):809–816. doi: 10.1093/brain/106.4.809. [DOI] [PubMed] [Google Scholar]
  18. Ohman S., Forsberg P., Nelson N., Vrethem M. An improved formula for the judgement of intrathecally produced IgG in the presence of blood brain barrier damage. Clin Chim Acta. 1989 May 31;181(3):265–272. doi: 10.1016/0009-8981(89)90232-5. [DOI] [PubMed] [Google Scholar]
  19. Paty D. W., Oger J. J., Kastrukoff L. F., Hashimoto S. A., Hooge J. P., Eisen A. A., Eisen K. A., Purves S. J., Low M. D., Brandejs V. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988 Feb;38(2):180–185. doi: 10.1212/wnl.38.2.180. [DOI] [PubMed] [Google Scholar]
  20. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  21. Reiber H., Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta. 1987 Mar 30;163(3):319–328. doi: 10.1016/0009-8981(87)90250-6. [DOI] [PubMed] [Google Scholar]
  22. Sandberg-Wollheim M., Bynke H., Cronqvist S., Holtås S., Platz P., Ryder L. P. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. 1990 Apr;27(4):386–393. doi: 10.1002/ana.410270406. [DOI] [PubMed] [Google Scholar]
  23. Schuller E., Sagar H. J. Central nervous system IgG synthesis in multiple sclerosis. Application of a new formula. Acta Neurol Scand. 1983 Jun;67(6):365–371. doi: 10.1111/j.1600-0404.1983.tb03154.x. [DOI] [PubMed] [Google Scholar]
  24. Sharief M. K., Thompson E. J. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann Neurol. 1991 Feb;29(2):147–151. doi: 10.1002/ana.410290206. [DOI] [PubMed] [Google Scholar]
  25. Städt D., Kappos L., Rohrbach E., Heun R., Ratzka M. Occurrence of MRI abnormalities in patients with isolated optic neuritis. Eur Neurol. 1990;30(6):305–309. doi: 10.1159/000117361. [DOI] [PubMed] [Google Scholar]
  26. Tola M. R., Granieri E., Caniatti L., Paolino E., Monetti C., Dovigo L., Scolozzi R., De Bastiani P., Carreras M. Systemic lupus erythematosus presenting with neurological disorders. J Neurol. 1992 Feb;239(2):61–64. doi: 10.1007/BF00862972. [DOI] [PubMed] [Google Scholar]
  27. Tourtellotte W. W., Ma B. I. Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 1978 Sep;28(9 Pt 2):76–83. doi: 10.1212/wnl.28.9_part_2.76. [DOI] [PubMed] [Google Scholar]
  28. Tourtellotte W. W., Potvin A. R., Fleming J. O., Murthy K. N., Levy J., Syndulko K., Potvin J. H. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology. 1980 Mar;30(3):240–244. doi: 10.1212/wnl.30.3.240. [DOI] [PubMed] [Google Scholar]
  29. Vandvik B., Skrede S. Electrophoretic examination of cerebrospinal fluid proteins in multiple sclerosis and other neurological diseases. Eur Neurol. 1973;9(4):224–241. doi: 10.1159/000114228. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES